apollo
0
Written By Veda Maddala , M Pharmacy
Reviewed By Dr Aneela Siddabathuni , MPharma., PhD
Last Updated Aug 20, 2024 | 1:16 PM IST

About METALYSE 40MG INJECTION

METALYSE 40MG INJECTION belongs to the class of drugs called thrombolytics (clot-busting drugs) indicated to reduce the risk of death in people who have had a serious type of heart attack known as acute ST-elevation myocardial infarction (STEMI). Heart attack refers to blocked blood flow to the heart due to blockage of arteries. STEMI is a type of serious heart attack that mainly affects the lower chambers of the heart.

METALYSE 40MG INJECTION contains Tenecteplase, a clot-busting drug that helps to dissolve unwanted blood clots in the blood vessels of the heart. Thus, it helps to prevent damage caused by heart attack.

METALYSE 40MG INJECTION will be administered by a healthcare professional; do not self-administer. METALYSE 40MG INJECTION may cause common side effects such as bleeding, nosebleeds, bruising, bleeding at the injection or puncture site, or blood in the urine. If you notice such side effects, please inform your doctor.

If you are allergic to Tenecteplase or any other medicines, please tell your doctor. METALYSE 40MG INJECTION should be used with caution in patients aged over 75 years and who weigh less than 60 kg. METALYSE 40MG INJECTION is not recommended for children below 18 years of age as the safety and effectiveness were not established. If you are a pregnant or breastfeeding woman, please inform your doctor before receiving METALYSE 40MG INJECTION. If you have had a recent major surgery or trauma, inform your doctor. 

Uses of METALYSE 40MG INJECTION

Acute myocardial infarction (Heart attack)

Medicinal Benefits

METALYSE 40MG INJECTION contains Tenecteplase, a clot-busting drug indicated to reduce the risk of death in people who have had a serious type of heart attack known as acute ST-elevation myocardial infarction (STEMI). It helps to dissolve unwanted blood clots in the blood vessels of the heart. Thus, it helps to prevent damage caused by heart attack and has been shown to save lives.

Directions for Use

It will be administered by a healthcare professional; do not self-administer.

Storage

Store in a cool and dry place away from sunlight

Side Effects of METALYSE 40MG INJECTION

  • Bleeding
  • Nosebleeds
  • Bruising
  • Bleeding at the injection or puncture site
  • Blood in urine

Drug Warnings

If you are allergic to Tenecteplase or any other medicines, please tell your doctor. METALYSE 40MG INJECTION should be used with caution in patients aged over 75 years of age and who weigh less than 60 kg. METALYSE 40MG INJECTION is not recommended for children below 18 years of age as the safety and effectiveness were not established. If you are a pregnant or breastfeeding woman, please inform your doctor before receiving METALYSE 40MG INJECTION. If you have had a recent major surgery or trauma, inform your doctor. METALYSE 40MG INJECTION is not recommended if you have been given cardiopulmonary resuscitation (chest compressions) for more than 2 minutes duration in the last two weeks. You are advised to be careful while using sharp objects, cutting nails, or shaving, as METALYSE 40MG INJECTION may increase the risk of bleeding. 

Drug Interactions

Drug-Drug Interaction: METALYSE 40MG INJECTION may interact with blood thinners (ticlopidine, clopidogrel, heparin, vitamin K antagonists).

Drug-Food Interaction: No interactions found. 

Drug-Disease Interaction: METALYSE 40MG INJECTION is not recommended if you have or had a bleeding disorder or recent history of bleeding, brain tumour, stroke, severe high blood pressure, abnormality of the blood vessels or aneurysm or recent major surgery or trauma to your brain or spine. If you have or had recent major surgery or trauma, high blood pressure, severe liver failure, serious infection or inflammation, bleeding disorder, stroke, heart problems, or recent bleeding in the gastrointestinal or urinary systems, inform your doctor before receiving METALYSE 40MG INJECTION.

Drug-Drug Interactions Checker List

  • TICLOPIDINE
  • CLOPIDOGREL
  • HEPARIN

Habit Forming

No

Diet & Lifestyle Advise

  • Maintain a diet consisting of vegetables, whole grains, fruits and lean protein.
  • Reduce sugar and processed foods.
  • Include foods high in antioxidants, such as vegetables, fruits, olive oil, seeds, nuts, cocoa, and red wine, as they may lower the risk of developing blood clots.
  • Adopt an anti-inflammatory diet high in omega-3-rich foods, fruits and vegetables, and vitamin-E-rich foods.
  • Drink plenty of fluids as dehydration can thicken blood leading to an increased risk of blood clot formation.
  • Do regular exercise as it helps to dissolve blood clots, especially in obese people.
  • Quit smoking and also avoid being around secondhand smoke.

Disease/Condition Glossary

Acute myocardial infarction (Heart attack): It refers to blocked blood flow to the heart due to acute blockage of arteries. A blockage can develop due to a buildup of plaque, a substance mostly made of cholesterol, fat, or cellular waste products or due to a sudden blood clot that forms on the blockage. The symptoms include chest pain, shortness of breath, sweating, anxiety, and a fast heart rate. Acute ST-elevation myocardial infarction (STEMI) is a type of serious heart attack that mainly affects the lower chambers of the heart and causes a distinct pattern on ECG (electrocardiogram).

About METALYSE 40MG INJECTION

METALYSE 40MG INJECTION belongs to the class of drugs called thrombolytics (clot-busting drugs) indicated to reduce the risk of death in people who have had a serious type of heart attack known as acute ST-elevation myocardial infarction (STEMI). Heart attack refers to blocked blood flow to the heart due to blockage of arteries. STEMI is a type of serious heart attack that mainly affects the lower chambers of the heart.

METALYSE 40MG INJECTION contains Tenecteplase, a clot-busting drug that helps to dissolve unwanted blood clots in the blood vessels of the heart. Thus, it helps to prevent damage caused by heart attack.

METALYSE 40MG INJECTION will be administered by a healthcare professional; do not self-administer. METALYSE 40MG INJECTION may cause common side effects such as bleeding, nosebleeds, bruising, bleeding at the injection or puncture site, or blood in the urine. If you notice such side effects, please inform your doctor.

If you are allergic to Tenecteplase or any other medicines, please tell your doctor. METALYSE 40MG INJECTION should be used with caution in patients aged over 75 years and who weigh less than 60 kg. METALYSE 40MG INJECTION is not recommended for children below 18 years of age as the safety and effectiveness were not established. If you are a pregnant or breastfeeding woman, please inform your doctor before receiving METALYSE 40MG INJECTION. If you have had a recent major surgery or trauma, inform your doctor. 

Non returnable*
COD available

Online payment accepted

Prescription drug

Whats That

tooltip
Non returnable*
COD available

Online payment accepted

Consume Type

PARENTERAL

Return Policy

Not Returnable

Expires on or after

Apr-24

for this medicine

Uses of METALYSE 40MG INJECTION

Acute myocardial infarction (Heart attack)

Medicinal Benefits

METALYSE 40MG INJECTION contains Tenecteplase, a clot-busting drug indicated to reduce the risk of death in people who have had a serious type of heart attack known as acute ST-elevation myocardial infarction (STEMI). It helps to dissolve unwanted blood clots in the blood vessels of the heart. Thus, it helps to prevent damage caused by heart attack and has been shown to save lives.

Side Effects of METALYSE 40MG INJECTION

  • Bleeding
  • Nosebleeds
  • Bruising
  • Bleeding at the injection or puncture site
  • Blood in urine

Directions for Use

It will be administered by a healthcare professional; do not self-administer.

Storage

Store in a cool and dry place away from sunlight

Drug Warnings

If you are allergic to Tenecteplase or any other medicines, please tell your doctor. METALYSE 40MG INJECTION should be used with caution in patients aged over 75 years of age and who weigh less than 60 kg. METALYSE 40MG INJECTION is not recommended for children below 18 years of age as the safety and effectiveness were not established. If you are a pregnant or breastfeeding woman, please inform your doctor before receiving METALYSE 40MG INJECTION. If you have had a recent major surgery or trauma, inform your doctor. METALYSE 40MG INJECTION is not recommended if you have been given cardiopulmonary resuscitation (chest compressions) for more than 2 minutes duration in the last two weeks. You are advised to be careful while using sharp objects, cutting nails, or shaving, as METALYSE 40MG INJECTION may increase the risk of bleeding. 

Therapeutic Class

THROMBOLYTIC ENZYME

Drug-Drug Interactions Checker List

  • TICLOPIDINE
  • CLOPIDOGREL
  • HEPARIN

Diet & Lifestyle Advise

  • Maintain a diet consisting of vegetables, whole grains, fruits and lean protein.
  • Reduce sugar and processed foods.
  • Include foods high in antioxidants, such as vegetables, fruits, olive oil, seeds, nuts, cocoa, and red wine, as they may lower the risk of developing blood clots.
  • Adopt an anti-inflammatory diet high in omega-3-rich foods, fruits and vegetables, and vitamin-E-rich foods.
  • Drink plenty of fluids as dehydration can thicken blood leading to an increased risk of blood clot formation.
  • Do regular exercise as it helps to dissolve blood clots, especially in obese people.
  • Quit smoking and also avoid being around secondhand smoke.

Habit Forming

No

Disease/Condition Glossary

Acute myocardial infarction (Heart attack): It refers to blocked blood flow to the heart due to acute blockage of arteries. A blockage can develop due to a buildup of plaque, a substance mostly made of cholesterol, fat, or cellular waste products or due to a sudden blood clot that forms on the blockage. The symptoms include chest pain, shortness of breath, sweating, anxiety, and a fast heart rate. Acute ST-elevation myocardial infarction (STEMI) is a type of serious heart attack that mainly affects the lower chambers of the heart and causes a distinct pattern on ECG (electrocardiogram).